These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21249225)

  • 1. Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection.
    Lukoye D; Cobelens FG; Ezati N; Kirimunda S; Adatu FE; Lule JK; Nuwaha F; Joloba ML
    PLoS One; 2011 Jan; 6(1):e16130. PubMed ID: 21249225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.
    Lukoye D; Katabazi FA; Musisi K; Kateete DP; Asiimwe BB; Okee M; Joloba ML; Cobelens FG
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3853-9. PubMed ID: 24777100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
    Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
    BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis drug resistance and HIV infection, the Netherlands.
    Haar CH; Cobelens FG; Kalisvaart NA; van der Have JJ; van Gerven PJ; van Soolingen D
    Emerg Infect Dis; 2007 May; 13(5):776-8. PubMed ID: 17553264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis.
    Eldholm V; Rieux A; Monteserin J; Lopez JM; Palmero D; Lopez B; Ritacco V; Didelot X; Balloux F
    Elife; 2016 Aug; 5():. PubMed ID: 27502557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Ssengooba W; Lukoye D; Meehan CJ; Kateete DP; Joloba ML; de Jong BC; Cobelens FG; van Leth F
    Int J Tuberc Lung Dis; 2017 May; 21(5):531-536. PubMed ID: 28399968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.
    Kirenga BJ; Ssengooba W; Muwonge C; Nakiyingi L; Kyaligonza S; Kasozi S; Mugabe F; Boeree M; Joloba M; Okwera A
    BMC Public Health; 2015 Jan; 15():13. PubMed ID: 25604986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam.
    Mai TQ; Van Anh NT; Hien NT; Lan NH; Giang DC; Hang PTT; Lan NTN; Marais BJ; Sintchenko V
    J Glob Antimicrob Resist; 2017 Sep; 10():154-160. PubMed ID: 28743648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Bisson GP; Bastos M; Campbell JR; Bang D; Brust JC; Isaakidis P; Lange C; Menzies D; Migliori GB; Pape JW; Palmero D; Baghaei P; Tabarsi P; Viiklepp P; Vilbrun S; Walsh J; Marks SM
    Lancet; 2020 Aug; 396(10248):402-411. PubMed ID: 32771107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of drug-resistant Mycobacterium tuberculosis and its relationship to HIV infection.
    Spellman CW; Matty KJ; Weis SE
    AIDS; 1998 Jan; 12(2):191-5. PubMed ID: 9468368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing multiple and extensively drug-resistant tuberculosis and HIV.
    Padayatchi N; Friedland G
    Expert Opin Pharmacother; 2007 Jun; 8(8):1035-7. PubMed ID: 17516869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin.
    Affolabi D; Adjagba OA; Tanimomo-Kledjo B; Gninafon M; Anagonou SY; Portaels F
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1221-4. PubMed ID: 17958985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997.
    Bretzel G; Aziz M; Wendl-Richter U; Adatu F; Aisu T; van Wijnen A; Sticht-Groh V
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):810-5. PubMed ID: 10488890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.